Sanofi (OTCMKTS:SNYNF – Get Free Report) was the recipient of a significant decline in short interest in the month of June. As of June 15th, there was short interest totaling 167,782 shares, a decline of 39.1% from the May 31st total of 275,393 shares. Based on an average trading volume of 6,920 shares, the short-interest ratio is presently 24.2 days.
Sanofi Trading Up 4.2%
Shares of Sanofi stock opened at $84.71 on Friday. Sanofi has a 52 week low of $80.74 and a 52 week high of $106.34. The company’s 50-day moving average price is $87.17 and its two-hundred day moving average price is $91.43.
About Sanofi
Sanofi is a multinational biopharmaceutical company headquartered in Paris, France, specializing in the research, development and manufacturing of prescription medicines, vaccines and consumer healthcare products. With a strategic focus on specialty care, vaccines, and general medicines, Sanofi’s portfolio addresses a broad range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology and rare diseases. The company operates through distinct business segments, each dedicated to advancing patient care through innovative therapies and preventive solutions.
In its pharmaceuticals segment, Sanofi develops and markets biologics and small molecules designed to treat chronic and acute conditions.
Recommended Stories
- Five stocks we like better than Sanofi
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.
